Formula | C2H4O2S |
MW | 92.11 |
InChIKey | CWERGRDVMFNCDR-TULZNQERNA-N |
Entry_Date | 2023-09-01 |
Net_Charge | 0 |
Number_Atoms | 9 |
Number_Heavy_Atoms | 5 |
Number_Rings | 0 |
Number_Bonds | 8 |
Rotat_Bonds | 3 |
Unbranched_Chain | 2 |
Chiral_Centers | 0 |
ONatoms | 2 |
HB_Donor | 1 |
HB_Acceptor | 2 |
OpenEye_HB_Donors | 2 |
OpenEye_HB_Acceptors | 1 |
Lipinski_HB_Donors | 1 |
Lipinski_HB_Acceptors | 2 |
Lipinski_Violations | 0 |
XLogP3 | 0 |
XLogP | -0.54 |
logP | 0.0008 |
PSA | 76.1 |
MR | 21.4288 |
ABS | 0.55 |
Solubility | very |
Aggregator | Pass |
PM7_Heat_of_Formation_kcal_per_mol | -86.8102 |
PM7_Total_Energy_ev | -1067.33943 |
PM7_Electronic_Energy_ev | -3279.10544 |
PM7_Dipole_Debye | 3.12951 |
PM7_Point_Group | Cs |
PM7_HOMO_Energy_ev | -9.211 |
PM7_LUMO_Energy_ev | -0.648 |
PM7_COSMO_Area_square_ang | 116.05 |
PM7_COSMO_Volue_cubic_ang | 102.6 |
PM7_Electron_Affinity_ev | 0.648 |
PM7_Ionization_Energy_ev | 9.211 |
PM7_Energy_Gap_ev | 8.563 |
PM7_Global_Hardness_ev | 4.2815 |
PM7_Global_Softness_ev | 0.23356300362022656 |
PM7_Chemical_Potential_ev | -4.9295 |
PM7_Electronigativity_ev | 4.9295 |
PM7_Back_Donation_Energy_ev | -1.070375 |
PM7_Electrophilicity_ev | 2.8377870197360737 |
OPENEYE_Name | 2-sulfanylacetic acid |
SMILES | C(=O)(CS)O |
Canonical_SMILES | OC(=O)CS |
InChI | 1/C2H4O2S/c3-2(4)1-5/h5H,1H2,(H,3,4)/f/h3H |
InChI_3D | 1S/C2H4O2S/c3-2(4)1-5/h5H,1H2,(H,3,4) |
AuxInfo | 1/1/N:2,1,3,4,5/E:(3,4)/F:2,1,4,3,5/rA:9nCCOOSHHHH/rB:s1;d1;s1;s2;s2;s2;s4;s5;/rC:;-.5,-.866,0;1,0,0;-.5,.866,0;-1,-1.7321,0;-.067,-1.116,0;-.933,-.616,0;-.25,1.299,0;-.75,-2.1651,0; |
Duplicates | DB15429 |
mol2_Path | /CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000015250-0000015499/DB15429.mol2 |
pdbqt_Path | /CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000015250-0000015499/DB15429.pdbqt |
sdf_Path | /CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000015250-0000015499/DB15429.sdf |